Tilray Brands Inc vs Visa Inc — how do they compare? Tilray Brands Inc trades at $4.21 (market cap $591.60M), while Visa Inc trades at $369.88 (market cap $693.57B). The key difference: Visa Inc is far larger — about 1172.4× Tilray Brands Inc's market cap, and Visa Inc pays a 0.73% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| TLRY | V | |
|---|---|---|
Market Cap | $591.60M | $693.57B |
Sector | Health | Financials |
52-Week High | $21.00 | $384.14 |
52-Week Low | $3.88 | $295.52 |
Enterprise Value | $758.73M | $704.15B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.73% |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
Visa (V) trades at $368.64, down 1.71% on the day, but maintains strong fundamentals with a 50.78% net income margin and consistent earnings beats. The stock is supported by a bullish technical signal, with key support at $366 and resistance at $372. Recent developments include the launch of Intelligent Commerce Connect to facilitate AI-driven commerce, positioning the company for future growth amid digital payment expansion.
The outlook for Visa remains positive, driven by robust profitability, strategic AI initiatives, and a consensus price target of $430.93 implying 17% upside. Risks include competitive pressures from fintech and stablecoins, as well as regulatory scrutiny. Wall Street sentiment is overwhelmingly bullish with 85% of analysts rating it a Buy, supported by institutional accumulation.
Trailing returns across standard periods
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →